S&P 500 Tries Its Best to Rebound With Best Day In A Year | Wall Street Today

Moomoo Recap US16:56 ET

Gilead Sciences in Charts: Sales From HIV, Liver Disease, and Oncology Therapies Advances in Q2

Seeking Alpha16:20 ET

Gilead Sciences Non-GAAP EPS of $2.01 Beats by $0.41, Revenue of $6.95B Beats by $210M

Seeking Alpha16:04 ET

Pyxis Oncology Draws Buy at Stifel on Lead Asset

Seeking Alpha15:32 ET

Pfizer Analyst Ratings

Benzinga13:38 ET · Ratings

10 Health Care Stocks Whale Activity In Today's Session

Benzinga13:35 ET